ATE1019T1 - Hyaluronidase und seine herstellung. - Google Patents
Hyaluronidase und seine herstellung.Info
- Publication number
- ATE1019T1 ATE1019T1 AT79101420T AT79101420T ATE1019T1 AT E1019 T1 ATE1019 T1 AT E1019T1 AT 79101420 T AT79101420 T AT 79101420T AT 79101420 T AT79101420 T AT 79101420T AT E1019 T1 ATE1019 T1 AT E1019T1
- Authority
- AT
- Austria
- Prior art keywords
- hyaluronidase
- manufacture
- chondroitin
- hexosaminidase
- endo
- Prior art date
Links
- 108010003272 Hyaluronate lyase Proteins 0.000 title abstract 2
- 102000001974 Hyaluronidases Human genes 0.000 title abstract 2
- 229960002773 hyaluronidase Drugs 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 abstract 1
- 229920002567 Chondroitin Polymers 0.000 abstract 1
- 229920001287 Chondroitin sulfate Polymers 0.000 abstract 1
- 241001052688 Streptomyces koganeiensis Species 0.000 abstract 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 abstract 1
- 229940059329 chondroitin sulfate Drugs 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 229960003160 hyaluronic acid Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP53056313A JPS6033474B2 (ja) | 1978-05-11 | 1978-05-11 | 新規なヒアルロニダ−ゼｂｍｐ−８２３１およびその製造法 |
| EP79101420A EP0005751B1 (de) | 1978-05-11 | 1979-05-10 | Hyaluronidase und seine Herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE1019T1 true ATE1019T1 (de) | 1982-05-15 |
Family
ID=13023655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT79101420T ATE1019T1 (de) | 1978-05-11 | 1979-05-10 | Hyaluronidase und seine herstellung. |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4258134A (de) |
| EP (1) | EP0005751B1 (de) |
| JP (1) | JPS6033474B2 (de) |
| AT (1) | ATE1019T1 (de) |
| DE (1) | DE2962780D1 (de) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4801475A (en) * | 1984-08-23 | 1989-01-31 | Gregory Halpern | Method of hydrophilic coating of plastics |
| GB8504025D0 (en) * | 1985-02-16 | 1985-03-20 | Biopharm Ltd | Hyaluronidase |
| SE456245B (sv) * | 1986-07-09 | 1988-09-19 | Pharmacia Ab | Enzympreparation innehallande krillhyaluronidas |
| JP2699078B2 (ja) * | 1987-12-23 | 1998-01-19 | 北里研究所（社団法人） | ムシン分解酵素及びその製造法 |
| US6610292B2 (en) | 1995-11-22 | 2003-08-26 | Ista Pharmaceuticals, Inc. | Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders |
| US5866120A (en) * | 1995-11-22 | 1999-02-02 | Advanced Corneal Systems, Inc. | Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase |
| WO1999045869A1 (en) * | 1998-03-09 | 1999-09-16 | Ista Pharmaceuticals, Inc. | Use of corneal hardening agents in enzyme orthokeratology |
| AU758575C (en) | 1998-04-30 | 2003-11-20 | Maruha Corporation | Compounds having glucuronic acid derivative and glucosamine derivative in structure thereof, method for producing the compounds, and uses of the compounds |
| RU2174557C1 (ru) * | 2000-11-22 | 2001-10-10 | Предприятие по производству бакпрепаратов научно-исследовательского института эпидемиологии и микробиологии им. Н.Ф. Гамалеи РАМН | Способ получения гиалуронидазы стрептококковой |
| NZ542873A (en) | 2003-03-05 | 2008-07-31 | Halozyme Inc | Soluble, neutral-active hyaluronidase activity glycoprotein (sHASEGP) that is produced with high yield in a mammalian expression system by introducing nucleic acids that lack a narrow region encoding amino acids in the carboxy terminus of the human PH20 cDNA |
| MXPA03011987A (es) | 2003-12-19 | 2005-06-23 | Osio Sancho Alberto | Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal. |
| MY152979A (en) | 2008-01-09 | 2014-12-15 | Sanofi Aventis Deutschland | Novel insulin derivatives having an extremely delayed time-action profile |
| RS59913B1 (sr) | 2008-10-17 | 2020-03-31 | Sanofi Aventis Deutschland | Kombinacija insulina i glp-1-agonista |
| US20120219554A2 (en) * | 2009-05-14 | 2012-08-30 | Fidia Farmaceutici S.P.A. | Extracellular yaluronidase from streptomyces koganeiensis |
| CN102596175A (zh) * | 2009-07-06 | 2012-07-18 | 赛诺菲-安万特德国有限公司 | 含有甲硫氨酸的水性胰岛素制备物 |
| PT3345593T (pt) | 2009-11-13 | 2023-11-27 | Sanofi Aventis Deutschland | Composição farmacêutica compreendendo despro36exendina- 4(1-39)-lys6-nh2 e metionina |
| MY180661A (en) | 2009-11-13 | 2020-12-04 | Sanofi Aventis Deutschland | Pharmaceutical composition comprising a glp-1 agonist, an insulin and methionine |
| CZ2009835A3 (cs) | 2009-12-11 | 2011-06-22 | Contipro C A.S. | Zpusob prípravy derivátu kyseliny hyaluronové oxidovaného v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd a zpusob jeho modifikace |
| CZ302504B6 (cs) | 2009-12-11 | 2011-06-22 | Contipro C A.S. | Derivát kyseliny hyaluronové oxidovaný v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd, zpusob jeho prípravy a zpusob jeho modifikace |
| PL2611458T3 (pl) | 2010-08-30 | 2017-02-28 | Sanofi-Aventis Deutschland Gmbh | Zastosowanie AVE0010 do produkcji leku do leczenia cukrzycy typu 2 |
| US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
| AR087693A1 (es) | 2011-08-29 | 2014-04-09 | Sanofi Aventis Deutschland | Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2 |
| TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
| CZ2012136A3 (cs) | 2012-02-28 | 2013-06-05 | Contipro Biotech S.R.O. | Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití |
| EP2877589B1 (de) | 2012-07-26 | 2024-03-06 | Momenta Pharmaceuticals, Inc. | Glykoproteine mit entzündungshemmenden eigenschaften |
| CZ304512B6 (cs) | 2012-08-08 | 2014-06-11 | Contipro Biotech S.R.O. | Derivát kyseliny hyaluronové, způsob jeho přípravy, způsob jeho modifikace a použití |
| DK2883104T3 (da) | 2012-08-10 | 2024-07-29 | Osio Corp D/B/A Yolia Health | Anvendelse af kontaktlinse ved behandling af en ofthalmologisk lidelse |
| CZ2012664A3 (cs) | 2012-09-27 | 2013-11-13 | Contipro Biotech S.R.O. | Enzym hyaluronan-lyáza, zpusob jeho výroby, pouzití a zpusob prípravy nízkomolekulárního hyaluronanu |
| CZ2012842A3 (cs) | 2012-11-27 | 2014-08-20 | Contipro Biotech S.R.O. | Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití |
| TWI780236B (zh) | 2013-02-04 | 2022-10-11 | 法商賽諾菲公司 | 胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物 |
| WO2014186310A1 (en) | 2013-05-13 | 2014-11-20 | Momenta Pharmaceuticals, Inc. | Methods for the treatment of neurodegeneration |
| ITMI20130992A1 (it) | 2013-06-17 | 2014-12-18 | Fidia Farmaceutici | Ialuronidasi batterica e metodo per la sua produzione |
| WO2015057622A1 (en) | 2013-10-16 | 2015-04-23 | Momenta Pharmaceuticals, Inc. | Sialylated glycoproteins |
| MX2016008979A (es) | 2014-01-09 | 2016-10-04 | Sanofi Sa | Formulaciones farmaceuticas estabilizadas de analogos de insulina y/o derivados de insulina. |
| BR112016015851A2 (pt) | 2014-01-09 | 2017-08-08 | Sanofi Sa | Formulações farmacêuticas estabilizadas de insulina aspart |
| MX2016008978A (es) | 2014-01-09 | 2016-10-04 | Sanofi Sa | Formulaciones farmaceuticas de analogos de insulina y/o derivados de insulina estabilizadas y que estan libres de glicerol. |
| CZ305153B6 (cs) | 2014-03-11 | 2015-05-20 | Contipro Biotech S.R.O. | Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití |
| CZ2014451A3 (cs) | 2014-06-30 | 2016-01-13 | Contipro Pharma A.S. | Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití |
| EP3229828B1 (de) | 2014-12-12 | 2023-04-05 | Sanofi-Aventis Deutschland GmbH | Insulin-glargin/lixisenatid-fixierte verhältnisformulierung |
| CZ309295B6 (cs) | 2015-03-09 | 2022-08-10 | Contipro A.S. | Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití |
| TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患治療 |
| TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患之治療 |
| CZ306479B6 (cs) | 2015-06-15 | 2017-02-08 | Contipro A.S. | Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin |
| CZ306662B6 (cs) | 2015-06-26 | 2017-04-26 | Contipro A.S. | Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití |
| CZ308106B6 (cs) | 2016-06-27 | 2020-01-08 | Contipro A.S. | Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1946682A1 (de) | 1968-09-21 | 1971-01-28 | Amano Pharma Co Ltd | Verfahren zur Herstellung von Hyaluronidase |
| US3728223A (en) * | 1971-10-08 | 1973-04-17 | Amano Pharma Co Ltd | Production of hyaluronidase from a strain of streptomyces |
| JPS5413510B2 (de) * | 1973-08-28 | 1979-05-31 | ||
| SU513075A1 (ru) * | 1974-09-09 | 1976-05-05 | Московский технологический институт пищевой промышленности | Способ получени гиалуронидазы |
-
1978
- 1978-05-11 JP JP53056313A patent/JPS6033474B2/ja not_active Expired
-
1979
- 1979-05-03 US US06/035,719 patent/US4258134A/en not_active Expired - Lifetime
- 1979-05-10 EP EP79101420A patent/EP0005751B1/de not_active Expired
- 1979-05-10 AT AT79101420T patent/ATE1019T1/de not_active IP Right Cessation
- 1979-05-10 DE DE7979101420T patent/DE2962780D1/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE2962780D1 (en) | 1982-07-01 |
| EP0005751A1 (de) | 1979-12-12 |
| JPS6033474B2 (ja) | 1985-08-02 |
| US4258134A (en) | 1981-03-24 |
| EP0005751B1 (de) | 1982-05-12 |
| JPS54147997A (en) | 1979-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE1019T1 (de) | Hyaluronidase und seine herstellung. | |
| FI73995B (fi) | Foerfarande foer framstaellning av farmakologiskt vaerdefulla 6,11-dihydro-dibenso-/b,e/-tiepin-11-n-alkyl- norskopinetrar. | |
| FI851637L (fi) | 1,4-dihydro-4-oxonaftyridinderivat och deras salter, foerfarande foer framstaellning av dessa och dessa omfattande antibakteriella aemnen. | |
| BR7903563A (pt) | Processo de formacao de estrutura abobadada e respectiva disposicao construtiva | |
| ES262762Y (es) | "estructura de casquillo". | |
| GB2083459B (en) | New substituted heterocyclic benzamides and their production | |
| IT7923672A0 (it) | Composizioni vulcanizzabili e loro procedimento di fabbricazione. | |
| ATE1500T1 (de) | 6-chlor-2,3-dihydroxy-1,4-naphthochinon und seine 2,3-diester, und ihre herstellung. | |
| DK240979A (da) | 3-azabicyclo (3,1,0) hexanderivater | |
| DE3576697D1 (de) | Perfluoralkylvinylpolymer und seine herstellung. | |
| NL7903010A (nl) | Plantenkweeklichaam. | |
| AR241108A2 (es) | Insecticidas piretroides, acidos ciclopropancarboxilicos y esteres intermediarios y sus precedimientos de preparacion | |
| NO885465D0 (no) | Absorpsjon av hydrogensulfid. | |
| BE875377A (fr) | Matieres plastiques ignifugees, et agents ignifuges appropries | |
| DK266679A (da) | 3-azabicyclo (3.1.0) hexanderivater | |
| BG28978A3 (en) | Fungicide means and method for fighting the fungus | |
| DE3782698D1 (de) | 5-fluoruridin-derivat und dessen herstellung. | |
| DE3878988D1 (de) | 1,2-di(4-isobutylphenyl)aethylen, dessen herstellung und verwendung als zwischenprodukt. | |
| BE875273A (fr) | 0-carbamoyloximes de 2,3-dihydro-4h-1-benzo-pyranne-4-ones | |
| NL185583B (nl) | Luchtbehandelingskast. | |
| SU647509A1 (ru) | Вентил ционное устройство | |
| IT8524166V0 (it) | Pupazzo animato con occhi telescopici. | |
| AU526670B2 (en) | Production of 5.6 dihydro-2-methyl-n-phenyl-1,4-oxathiin-3- carboxamide | |
| FI792770A7 (fi) | Foerfarande foer framstaellning av 1,2,3-tiadiazol-5-ylkarbamider | |
| JPS5517393A (en) | Nncyclohexyllnnmethoxyacetoacetoamide*and its use for manufacturing oomethyllnncyclohexyll 2*55dimethylfurann33hydroxamic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |